Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial

  1. Garcia Campelo, M.R.
  2. Wan, Y.
  3. Lin, H.M.
  4. Chen, T.
  5. Shen, J.
  6. Zhang, P.
  7. Camidge, D.R.
Journal:
Lung Cancer

ISSN: 1872-8332,  0169-5002

Year of publication: 2023

Volume: 185

Type: Article

DOI: 10.1016/J.LUNGCAN.2023.107376 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus